Invirsa
Developer of a pharmaceutical therapy designed to treat diabetic dry eye and other ocular conditions linked to DNA (Deoxyribonucleic Acid) damage. The company offers a novel, topically administered ey...
Valuation
$0
Share Price
N/A
Total Raised
$14.3M
Last Round
N/A